Química Biológica
QuiBi
Foivos Sokratis
Lazaris
Investigador en el periodo 2021-2024
Publicaciones en las que colabora con Foivos Sokratis Lazaris (5)
2024
-
Non-natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity
XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book
-
Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity
Angewandte Chemie International Edition
-
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
JACS Au, Vol. 4, Núm. 1, pp. 150-163
2023
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
2022
-
Innovative cancer nano-vaccine based on a MUC1-like glycopeptide comprising unnatural amino acids
XXXVIII Reunión Bienal de la Real Sociedad Española de Química - RSEQ 2022 (Abstracts book)